nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—islet of Langerhans—pancreatic cancer	0.138	0.434	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—pancreas—pancreatic cancer	0.097	0.305	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—digestive system—pancreatic cancer	0.0829	0.261	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—APOE—pancreatic cancer	0.0165	0.0744	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOE—pancreatic cancer	0.0141	0.0635	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal discomfort—Tamoxifen—pancreatic cancer	0.0101	0.0219	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Sunitinib—pancreatic cancer	0.00953	0.0207	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Sunitinib—pancreatic cancer	0.00865	0.0188	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOE—pancreatic cancer	0.00843	0.038	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Erlotinib—pancreatic cancer	0.00726	0.0158	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Erlotinib—pancreatic cancer	0.00715	0.0155	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Sunitinib—pancreatic cancer	0.00628	0.0137	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Sunitinib—pancreatic cancer	0.00619	0.0135	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Erlotinib—pancreatic cancer	0.00581	0.0126	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Docetaxel—pancreatic cancer	0.00543	0.0118	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Tamoxifen—pancreatic cancer	0.00527	0.0115	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Erlotinib—pancreatic cancer	0.00521	0.0113	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Tamoxifen—pancreatic cancer	0.00521	0.0113	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00517	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Tamoxifen—pancreatic cancer	0.00516	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Erlotinib—pancreatic cancer	0.00515	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00511	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Erlotinib—pancreatic cancer	0.00511	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Irinotecan—pancreatic cancer	0.0051	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Sunitinib—pancreatic cancer	0.00503	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.0049	0.0106	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00484	0.0105	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Tamoxifen—pancreatic cancer	0.00473	0.0103	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Erlotinib—pancreatic cancer	0.00468	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Sunitinib—pancreatic cancer	0.00451	0.00981	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Sunitinib—pancreatic cancer	0.00446	0.00969	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GDI1—pancreatic cancer	0.00444	0.02	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GDI2—pancreatic cancer	0.00444	0.02	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00443	0.00962	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Sunitinib—pancreatic cancer	0.00442	0.00961	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Tamoxifen—pancreatic cancer	0.0043	0.00934	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Erlotinib—pancreatic cancer	0.00425	0.00924	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00419	0.00911	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Irinotecan—pancreatic cancer	0.00414	0.009	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Tamoxifen—pancreatic cancer	0.0041	0.0089	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Sunitinib—pancreatic cancer	0.00405	0.00881	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Erlotinib—pancreatic cancer	0.00405	0.00881	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00404	0.00877	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00397	0.00862	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Tamoxifen—pancreatic cancer	0.00396	0.0086	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Erlotinib—pancreatic cancer	0.00392	0.00851	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PRSS1—pancreatic cancer	0.00384	0.0173	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ZNRF3—pancreatic cancer	0.00384	0.0173	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Tamoxifen—pancreatic cancer	0.00381	0.00827	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Tamoxifen—pancreatic cancer	0.00378	0.0082	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Tamoxifen—pancreatic cancer	0.00377	0.0082	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Erlotinib—pancreatic cancer	0.00377	0.00819	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Tamoxifen—pancreatic cancer	0.00375	0.00815	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Erlotinib—pancreatic cancer	0.00374	0.00812	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Erlotinib—pancreatic cancer	0.00373	0.00811	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Irinotecan—pancreatic cancer	0.00372	0.00808	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Erlotinib—pancreatic cancer	0.00371	0.00807	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Sunitinib—pancreatic cancer	0.00368	0.008	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Irinotecan—pancreatic cancer	0.00367	0.00798	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Epirubicin—pancreatic cancer	0.00366	0.00795	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00365	0.00793	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Irinotecan—pancreatic cancer	0.00364	0.00791	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Docetaxel—pancreatic cancer	0.00358	0.00778	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Gemcitabine—pancreatic cancer	0.00358	0.00777	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Fluorouracil—pancreatic cancer	0.00356	0.00774	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Tamoxifen—pancreatic cancer	0.00356	0.00773	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00355	0.00772	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Gemcitabine—pancreatic cancer	0.00355	0.00771	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Erlotinib—pancreatic cancer	0.00352	0.00765	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Fluorouracil—pancreatic cancer	0.00352	0.00764	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Sunitinib—pancreatic cancer	0.00351	0.00763	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00349	0.00759	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—DTX1—pancreatic cancer	0.00347	0.0157	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00345	0.00751	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Sunitinib—pancreatic cancer	0.00339	0.00737	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.00339	0.00736	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Irinotecan—pancreatic cancer	0.00334	0.00726	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Sunitinib—pancreatic cancer	0.00326	0.00709	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Sunitinib—pancreatic cancer	0.00323	0.00703	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Sunitinib—pancreatic cancer	0.00323	0.00702	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PRSS1—pancreatic cancer	0.00322	0.0145	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Sunitinib—pancreatic cancer	0.00321	0.00698	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Sunitinib—pancreatic cancer	0.00305	0.00662	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Irinotecan—pancreatic cancer	0.00303	0.00659	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Gemcitabine—pancreatic cancer	0.00295	0.00642	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—DTX4—pancreatic cancer	0.00291	0.0131	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Irinotecan—pancreatic cancer	0.00289	0.00628	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Docetaxel—pancreatic cancer	0.00286	0.00622	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRLHR—pancreatic cancer	0.00286	0.0129	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PPP2R5B—pancreatic cancer	0.00283	0.0128	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Gemcitabine—pancreatic cancer	0.00282	0.00612	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Irinotecan—pancreatic cancer	0.00279	0.00607	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ARG2—pancreatic cancer	0.00279	0.0126	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Fluorouracil—pancreatic cancer	0.00277	0.00602	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HEY2—pancreatic cancer	0.00273	0.0123	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ZNRF3—pancreatic cancer	0.00269	0.0121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ACVR1B—pancreatic cancer	0.00269	0.0121	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Irinotecan—pancreatic cancer	0.00269	0.00584	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Fluorouracil—pancreatic cancer	0.00268	0.00581	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Irinotecan—pancreatic cancer	0.00266	0.00579	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Irinotecan—pancreatic cancer	0.00266	0.00578	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Irinotecan—pancreatic cancer	0.00265	0.00575	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Gemcitabine—pancreatic cancer	0.00262	0.00569	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Gemcitabine—pancreatic cancer	0.00259	0.00564	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Gemcitabine—pancreatic cancer	0.00259	0.00563	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Gemcitabine—pancreatic cancer	0.00258	0.0056	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Fluorouracil—pancreatic cancer	0.00257	0.00559	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Docetaxel—pancreatic cancer	0.00257	0.00559	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Fluorouracil—pancreatic cancer	0.00255	0.00554	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Fluorouracil—pancreatic cancer	0.00255	0.00554	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Docetaxel—pancreatic cancer	0.00254	0.00552	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Fluorouracil—pancreatic cancer	0.00253	0.00551	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HEY1—pancreatic cancer	0.00252	0.0114	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00252	0.00548	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Docetaxel—pancreatic cancer	0.00252	0.00547	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Irinotecan—pancreatic cancer	0.00251	0.00545	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Gemcitabine—pancreatic cancer	0.00244	0.00531	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TYMP—pancreatic cancer	0.00244	0.011	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DTX1—pancreatic cancer	0.00243	0.011	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SSTR3—pancreatic cancer	0.00243	0.011	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Epirubicin—pancreatic cancer	0.00241	0.00524	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Fluorouracil—pancreatic cancer	0.0024	0.00522	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00239	0.00519	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Epirubicin—pancreatic cancer	0.00238	0.00517	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SSTR1—pancreatic cancer	0.00233	0.0105	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Docetaxel—pancreatic cancer	0.00231	0.00502	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PPY—pancreatic cancer	0.00229	0.0103	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SSTR2—pancreatic cancer	0.00225	0.0101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—JAG2—pancreatic cancer	0.00224	0.0101	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Doxorubicin—pancreatic cancer	0.00223	0.00485	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MEN1—pancreatic cancer	0.00221	0.00995	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Doxorubicin—pancreatic cancer	0.0022	0.00478	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC2A2—pancreatic cancer	0.00219	0.00988	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCKBR—pancreatic cancer	0.00217	0.00977	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SHH—pancreatic cancer	0.00211	0.00949	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Docetaxel—pancreatic cancer	0.0021	0.00455	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—IAPP—pancreatic cancer	0.00208	0.00937	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DTX4—pancreatic cancer	0.00204	0.00919	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GLI1—pancreatic cancer	0.00204	0.00919	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.00201	0.00907	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Docetaxel—pancreatic cancer	0.002	0.00434	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HSPA1B—pancreatic cancer	0.002	0.00899	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00198	0.00894	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NRP1—pancreatic cancer	0.00198	0.00894	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GLP1R—pancreatic cancer	0.00197	0.00886	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—DPYD—pancreatic cancer	0.00193	0.00872	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Epirubicin—pancreatic cancer	0.00193	0.0042	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Docetaxel—pancreatic cancer	0.00193	0.0042	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HEY2—pancreatic cancer	0.00191	0.00861	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GAST—pancreatic cancer	0.00186	0.00841	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Docetaxel—pancreatic cancer	0.00186	0.00403	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Docetaxel—pancreatic cancer	0.00184	0.004	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Docetaxel—pancreatic cancer	0.00184	0.004	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC2A2—pancreatic cancer	0.00183	0.00827	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Docetaxel—pancreatic cancer	0.00183	0.00398	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.00182	0.00819	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00179	0.00388	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—JAG1—pancreatic cancer	0.00179	0.00805	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SCT—pancreatic cancer	0.00177	0.00797	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HEY1—pancreatic cancer	0.00177	0.00797	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.00175	0.0079	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Docetaxel—pancreatic cancer	0.00173	0.00377	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Epirubicin—pancreatic cancer	0.00173	0.00377	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Epirubicin—pancreatic cancer	0.00171	0.00372	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.0017	0.0037	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Epirubicin—pancreatic cancer	0.0017	0.00369	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CD44—pancreatic cancer	0.0017	0.00765	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCK—pancreatic cancer	0.00169	0.0076	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HSPA1A—pancreatic cancer	0.00168	0.00759	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CNR2—pancreatic cancer	0.00164	0.00741	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GLP1R—pancreatic cancer	0.00164	0.00741	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCKAR—pancreatic cancer	0.00162	0.00729	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00161	0.0035	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Doxorubicin—pancreatic cancer	0.0016	0.00349	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.0016	0.0072	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Doxorubicin—pancreatic cancer	0.00158	0.00344	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00157	0.00342	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Doxorubicin—pancreatic cancer	0.00157	0.00341	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JAG2—pancreatic cancer	0.00157	0.00707	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Epirubicin—pancreatic cancer	0.00156	0.00338	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MEN1—pancreatic cancer	0.00155	0.00696	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00149	0.00324	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SHH—pancreatic cancer	0.00147	0.00664	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOTCH4—pancreatic cancer	0.00146	0.0066	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IAPP—pancreatic cancer	0.00146	0.00656	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Doxorubicin—pancreatic cancer	0.00144	0.00313	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CD44—pancreatic cancer	0.00142	0.0064	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Epirubicin—pancreatic cancer	0.00141	0.00307	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTCH1—pancreatic cancer	0.0014	0.0063	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTHLH—pancreatic cancer	0.0014	0.0063	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.00139	0.00627	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.00138	0.00621	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GCG—pancreatic cancer	0.00136	0.00614	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Epirubicin—pancreatic cancer	0.00135	0.00293	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SMAD4—pancreatic cancer	0.00134	0.00604	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HES1—pancreatic cancer	0.00131	0.0059	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Doxorubicin—pancreatic cancer	0.00131	0.00284	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Epirubicin—pancreatic cancer	0.0013	0.00283	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—STK11—pancreatic cancer	0.00128	0.00577	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SST—pancreatic cancer	0.00128	0.00576	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Epirubicin—pancreatic cancer	0.00125	0.00272	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JAG1—pancreatic cancer	0.00125	0.00564	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Doxorubicin—pancreatic cancer	0.00125	0.00271	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOTCH3—pancreatic cancer	0.00125	0.00561	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Epirubicin—pancreatic cancer	0.00124	0.0027	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Epirubicin—pancreatic cancer	0.00124	0.0027	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Epirubicin—pancreatic cancer	0.00123	0.00268	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Doxorubicin—pancreatic cancer	0.00121	0.00262	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.0012	0.00542	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CNR1—pancreatic cancer	0.00118	0.00532	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Epirubicin—pancreatic cancer	0.00117	0.00254	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Doxorubicin—pancreatic cancer	0.00116	0.00252	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Doxorubicin—pancreatic cancer	0.00115	0.0025	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Doxorubicin—pancreatic cancer	0.00115	0.00249	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—TERT—pancreatic cancer	0.00115	0.00517	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Doxorubicin—pancreatic cancer	0.00114	0.00248	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GCG—pancreatic cancer	0.00114	0.00513	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TYMS—pancreatic cancer	0.0011	0.00497	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HIF1A—pancreatic cancer	0.0011	0.00494	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TSC2—pancreatic cancer	0.00109	0.00493	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AGTR1—pancreatic cancer	0.00109	0.0049	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Doxorubicin—pancreatic cancer	0.00108	0.00235	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STK11—pancreatic cancer	0.00107	0.00483	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOE—pancreatic cancer	0.00107	0.00482	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOTCH1—pancreatic cancer	0.000987	0.00445	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EGF—pancreatic cancer	0.000955	0.0043	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SMAD4—pancreatic cancer	0.000938	0.00423	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HES1—pancreatic cancer	0.000916	0.00413	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOE—pancreatic cancer	0.000896	0.00404	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CD—pancreatic cancer	0.000849	0.00383	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	0.000848	0.00382	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CG—pancreatic cancer	0.000809	0.00365	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TERT—pancreatic cancer	0.000803	0.00362	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARG—pancreatic cancer	0.000781	0.00352	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HIF1A—pancreatic cancer	0.000768	0.00346	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TSC2—pancreatic cancer	0.000766	0.00345	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOE—pancreatic cancer	0.000749	0.00338	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CB—pancreatic cancer	0.00074	0.00334	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KDR—pancreatic cancer	0.000734	0.00331	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTGS2—pancreatic cancer	0.000733	0.0033	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CD—pancreatic cancer	0.000711	0.0032	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NFKBIA—pancreatic cancer	0.000698	0.00315	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOTCH1—pancreatic cancer	0.000692	0.00312	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CG—pancreatic cancer	0.000676	0.00305	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGF—pancreatic cancer	0.000668	0.00301	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CTNNB1—pancreatic cancer	0.000656	0.00296	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTEN—pancreatic cancer	0.000639	0.00288	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CB—pancreatic cancer	0.00062	0.00279	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGS2—pancreatic cancer	0.000614	0.00277	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CD—pancreatic cancer	0.000594	0.00268	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SRC—pancreatic cancer	0.000593	0.00267	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT3—pancreatic cancer	0.000572	0.00258	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NRAS—pancreatic cancer	0.00057	0.00257	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTEN—pancreatic cancer	0.000535	0.00241	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MYC—pancreatic cancer	0.000531	0.0024	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFB1—pancreatic cancer	0.00053	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EGFR—pancreatic cancer	0.00052	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CB—pancreatic cancer	0.000518	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL8—pancreatic cancer	0.000498	0.00224	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KRAS—pancreatic cancer	0.000491	0.00221	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASP3—pancreatic cancer	0.000477	0.00215	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCND1—pancreatic cancer	0.000464	0.00209	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CTNNB1—pancreatic cancer	0.000459	0.00207	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CA—pancreatic cancer	0.000451	0.00203	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—pancreatic cancer	0.00045	0.00203	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTEN—pancreatic cancer	0.000448	0.00202	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HRAS—pancreatic cancer	0.000417	0.00188	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SRC—pancreatic cancer	0.000415	0.00187	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—pancreatic cancer	0.000404	0.00182	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT3—pancreatic cancer	0.0004	0.0018	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NRAS—pancreatic cancer	0.000399	0.0018	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CA—pancreatic cancer	0.000378	0.0017	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MYC—pancreatic cancer	0.000372	0.00168	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFB1—pancreatic cancer	0.000371	0.00167	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—pancreatic cancer	0.000368	0.00166	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGFR—pancreatic cancer	0.000364	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KRAS—pancreatic cancer	0.000344	0.00155	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CA—pancreatic cancer	0.000316	0.00142	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—pancreatic cancer	0.000309	0.00139	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TP53—pancreatic cancer	0.000306	0.00138	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HRAS—pancreatic cancer	0.000292	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—pancreatic cancer	0.000258	0.00116	CbGpPWpGaD
